Denmark
Advertising
Pharmaceutical
September 2010
Vol. 3, No. 12, Summer 2010
Nicolai Ellehuus
More
Nicolai Ellehuus: 1980: Born in Copenhagen, Denmark
Education:
2000-2003: Bachelor of Law, Copenhagen University, Denmark
2003-2004: Diplôme Administration et Politiques Internationales (Law degree) from the Université Pierre Mèndes France in Grenoble, France
2005-2006: Brittingham Viking Scholar at Law School of University of Wisconsin-Madison (LL.M. studies), USA
2003-2007: Master of Laws, Copenhagen University, Denmark
Work experience:
2000-2003: Legal trainee at public tribunal under Danish Justice Department
2004-2007: Legal trainee at international law firm working with intellectual property
2007-2009: Legal Counsel and Group AML Officer at international investment bank
2009- to-date: Attorney-at-Law and Corporate Counsel at Novo Nordisk
Nicolai Ellehuus
More
Nicolai Ellehuus: 1980: Born in Copenhagen, Denmark
Education:
2000-2003: Bachelor of Law, Copenhagen University, Denmark
2003-2004: Diplôme Administration et Politiques Internationales (Law degree) from the Université Pierre Mèndes France in Grenoble, France
2005-2006: Brittingham Viking Scholar at Law School of University of Wisconsin-Madison (LL.M. studies), USA
2003-2007: Master of Laws, Copenhagen University, Denmark
Work experience:
2000-2003: Legal trainee at public tribunal under Danish Justice Department
2004-2007: Legal trainee at international law firm working with intellectual property
2007-2009: Legal Counsel and Group AML Officer at international investment bank
2009- to-date: Attorney-at-Law and Corporate Counsel at Novo Nordisk
Novo Nordisk As
More
Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs more than 29,300 employees in 76 countries, and markets its products in 179 countries. Novo Nordisk sales totaled DKK 51.078 million (EUR 6.860 million) in 2009.
Denmark
Advertising
Pharmaceutical
September 2010
Vol. 3, No. 12, Summer 2010